Skip to Content

Bar-Coding Life

Biotech: Tiny tags to decode disease.

Bar codes have revolutionized how everyone from warehouse managers to pharmacists keeps track of items. Mountain View, CA-based SurroMed is using them to help biologists track genes, proteins and other molecules. SurroMed’s microscopic bar codes could eventually be used to identify and quantify thousands of different molecules in a sample of a fluid like blood, making biological and medical tests far more informative.

SurroMed’s “nanobarcodes” work much like conventional bar codes, except they are microscopic rods, striped with bands of gold, silver and other metals. Varying the width, number and order of the stripes could generate thousands, if not hundreds of thousands, of unique identifiers, says SurroMed CEO Gordon Ringold. The rods could be attached to probes that bind to specific biological molecules, forming bar-coded tags.

The problem with existing fluorescent tags, which are the workhorses in many of today’s biological tests, is that they only let researchers analyze a few different types of molecules at a time. With nanobarcodes, though, thousands of different tags could be added to a biological sample at once. A sample-reading device would then snap a microscopic image, and a computer would identify all the tagged molecules in the image by the nanobarcodes attached to them.

“This is like miniature supermarket technology,” says Chad Mirkin, director of the Institute for Nanotechnology at Northwestern University. “Conceptually, this is a major advance” in biological analysis, he adds. SurroMed hopes its nanobarcodes will help researchers identify patterns of perhaps hundreds of molecules that form molecular signatures for different diseases, and for different stages of illness and recovery. More complete knowledge of the molecules involved in disease could help researchers develop better drugs and could form the basis for highly specific diagnostic tests.

In preliminary studies, the company is using nanobarcodes to identify molecular signatures in diabetics’ blood, Alzheimer’s patients’ brain fluid and other biological samples. According to chief technical officer Michael Natan, the first commercial nanobarcodes for research could be available in the next couple of years.

Keep Reading

Most Popular

This new data poisoning tool lets artists fight back against generative AI

The tool, called Nightshade, messes up training data in ways that could cause serious damage to image-generating AI models. 

The Biggest Questions: What is death?

New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.

Rogue superintelligence and merging with machines: Inside the mind of OpenAI’s chief scientist

An exclusive conversation with Ilya Sutskever on his fears for the future of AI and why they’ve made him change the focus of his life’s work.

How to fix the internet

If we want online discourse to improve, we need to move beyond the big platforms.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.